Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-08 Sale | 2025-01-10 8:00 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $48.85 | $732,693 | 1,309,487 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 8:00 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,085 | $46.94 | $191,740 | 427,518 (Direct) | View |
| 2024-12-12 Purchase | 2024-12-16 06:00 am | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 20,000 | $49.54 | $990,775 | 20,000 (Direct) | View |
| 2024-12-11 Sale | 2024-12-13 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 4,540 | $48.76 | $221,363 | 431,603 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $46.07 | $307,057 | 260,798 (Direct) | View |
| 2024-12-04 Sale | 2024-12-06 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $46.58 | $698,654 | 1,324,487 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $59.12 | $394,041 | 267,463 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $59.22 | $888,320 | 1,339,487 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 8:02 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $56.26 | $374,954 | 274,128 (Direct) | View |
| 2024-10-02 Sale | 2024-10-04 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $56.23 | $2,249,307 | 1,354,487 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 8:03 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 6,665 | $47.56 | $316,969 | 280,793 (Direct) | View |
| 2024-09-04 Sale | 2024-09-06 8:02 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $47.62 | $1,904,841 | 1,394,487 (Direct) | View |
| 2024-08-23 Sale | 2024-08-23 8:05 pm | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 6,000 | $48.26 | $289,560 | 200,871 (Direct) | View |
| 2024-08-07 Sale | 2024-08-09 8:05 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 7,335 | $40.67 | $298,336 | 287,458 (Direct) | View |
| 2024-08-07 Sale | 2024-08-09 8:05 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 40,000 | $40.62 | $1,624,764 | 1,434,487 (Direct) | View |
| 2024-07-05 Sale | 2024-07-05 8:01 pm | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 15,000 | $37.26 | $558,900 | 1,474,487 (Direct) | View |
| 2024-07-03 Sale | 2024-07-05 8:01 pm | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 5,995 | $37.6 | $225,418 | 294,793 (Direct) | View |
| 2023-07-13 Purchase | 2023-07-17 8:00 pm | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 1,750,000 | $17 | $29,750,000 | 1,797,758 (Indirect Direct) | View |
| 2023-07-13 Purchase | 2023-07-17 8:00 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-02 Exercise | 2025-01-03 8:00 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,360 | $22.86 | 427,518 (Direct) | View |
| 2025-01-02 Exercise | 2025-01-03 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,360 | $0 | 427,518 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 8:01 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,815 | $22.86 | 431,603 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 8:01 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 1,815 | $0 | 431,603 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:02 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 357,036 | $0 | 357,036 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:02 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 124,962 | $0 | 124,962 (Direct) | View |
| 2024-12-09 Option Award | 2024-12-11 8:01 pm | N/A 2034-12-09 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 124,962 | $0 | 124,962 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:12 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 10,370 | $0 | 10,370 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:05 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 10,370 | $0 | 10,370 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:04 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director | 8,112 | $0 | 8,112 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:03 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director | 10,370 | $0 | 10,370 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:02 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 10,370 | $0 | 10,370 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:01 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director | 10,370 | $0 | 10,370 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:00 pm | N/A 2034-06-05 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director | 20,740 | $0 | 20,740 (Direct) | View |
| 2024-05-28 Option Award | 2024-05-30 8:07 pm | N/A 2034-05-28 | Apogee Therapeutics Inc. | APGE | Bollinger Lisa Director | 18,550 | $0 | 18,550 (Direct) | View |
| 2024-03-28 Other | 2024-04-01 5:44 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 498,765 | $0 | 9,006,126 (Indirect) | View |
| 2024-01-29 Other | 2024-01-31 4:31 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 943,695 | $0 | 1,046,027 (Indirect) | View |
| 2023-12-18 Option Award | 2023-12-20 8:01 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 175,345 | $0 | 175,345 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 175,345 | $0 | 175,345 (Direct) | View |
| 2023-12-18 Option Award | 2023-12-20 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 398,512 | $0 | 398,512 (Direct) | View |
| 2023-08-17 Option Award | 2023-08-21 4:06 pm | N/A 2033-08-17 | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 150,000 | $0 | 200,000 (Direct) | View |
| 2023-07-13 Option Award | 2023-07-17 8:01 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director | 47,758 | $0 | 47,758 (Direct) | View |
| 2023-07-13 Option Award | 2023-07-17 8:00 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 47,758 | $0 | 1,797,758 (Direct) | View |
| 2023-07-13 Option Award | 2023-07-17 8:00 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 95,516 | $0 | 988,045 (Direct) | View |
Ownership(A) | 2023-07-17 5:06 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 0 | $0 | 300,788 (Direct) | View |